We demonstrate utilizing combination of genetic, chemical loss and gain of function approaches that GPR43 is the critical sensor of SCFAs butyrate and propionate and demonstrate a novel role for SCFA–GPR43–ERK–NLRP3 axis in mitigating GVHD (summarized in Fig. 7). This evidence concerns the gene FFAR2 and graft versus host disease.